Abstract:• Biological functions of HDL helped explain the cardioprotective effect of HDL beyond its quantitative plasma levels • Coenzyme Q10 improves HDL-mediated cholesterol efflux capacity and anti-inflammatory properties of HDL in Chinese adults with dyslipidemia. • CoQ10 improved HDL-mediated CEC more significantly in older, female, or non-obese patients. • Improving the biological function of HDL is expected to open a new era for primary prevention of CVDs. Coenzyme Q10 (CoQ10) had shown promising effects in improving lipid and glycemic profile in dyslipidemic individuals in our previous work, but little is known about how it affects high-density lipoprotein (HDL) function in patients with dyslipidemia. The aim of this study was to explore the effects of CoQ10 supplementation on HDL function in people with dyslipidemia. A 24-week, randomized, double-blind, placebo-controlled trial was conducted in 101 people with dyslipidemia. All subjects were randomized into CoQ10 group (120mg/day, n=51) and placebo group (n=50). HDL-mediated cholesterol efflux capacity (CEC), HDL inflammatory index (HII) and HDL intrinsic oxidation were measured at baseline, 12 weeks and 24 weeks. CoQ10 supplementation for 24 weeks significantly improved HDL-mediated CEC (mean change: 1.21±2.44 vs -0.12±2.94, P =0.014) and reduced HII (mean change: -0.32±0.58 vs -0.05±0.49, P =0.014) compared with placebo. However, there was no significant difference in the effect of CoQ10 on HDL intrinsic oxidation between two groups after 24 weeks ( P =0.290). A positive correlation was found between the changes of CEC and HDL-C in CoQ10 group (r=0.303, P =0.032). Furthermore, we also found that the improved HDL functions were more obvious in elderly, female, or non-obese individuals, which indicated a specific population who benefits most from CoQ10 intervention. Our study suggested that supplementation of CoQ10 for 24 weeks can significantly improve HDL-mediated CEC and anti-inflammatory function of HDL in patients with dyslipidemia.

Coenzyme Q10 Consumption Promotes ABCG1-mediated Macrophage Cholesterol Efflux: a Randomized, Double-Blind, Placebo-Controlled, Cross-over Study in Healthy Volunteers.

Coenzyme Q10 promotes macrophage cholesterol efflux by regulation of the activator protein-1/miR-378/ATP-binding cassette transporter G1-signaling pathway.

The Effects of Coenzyme A on Serum Lipids in Patients with Hyperlipidemia: Results of A Multicenter Clinical Trial

Coenzyme Q10 supplementation improves cholesterol efflux capacity and antiinflammatory properties of high-density lipoprotein in Chinese adults with dyslipidemia

Coenzyme Q10 supplementation improves cholesterol efflux capacity and anti-inflammatory properties of HDL in Chinese adults with dyslipidemia

Effect and safety of coenzyme A on hyperlipidemia

Efficacy and Tolerability of Adding Coenzyme A 400 U/d Capsule to Stable Statin Therapy for the Treatment of Patients with Mixed Dyslipidemia: an 8-Week, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study

Treatment of Coenzyme Q10 for 24 Weeks Improves Lipid and Glycemic Profile in Dyslipidemic Individuals.

A New Food-grade Coenzyme Q10 Formulation Improves Bioavailability: Single and Repeated Pharmacokinetic Studies in Healthy Volunteers

Coenzyme Q10 Protects Against Hyperlipidemia-Induced Osteoporosis by Improving Mitochondrial Function via Modulating miR-130b-3p/PGC-1α Pathway

Non-invasive instrumental evaluation of coenzyme Q10 phytosome on endothelial reactivity in healthy non-smoking young volunteers: a double-blind, placebo-controlled cross-over clinical trial

Coenzyme Q10 Improves Lipid Metabolism and Ameliorates Obesity by Regulating CaMKII-Mediated PDE4 Inhibition

Total Coenzyme Q10 Concentrations in Asian Men Following Multiple Oral 50-Mg Doses Administered As Coenzyme Q10 Sustained Release Tablets or Regular Tablets.

Coenzyme Q10 mitigates macrophage mediated inflammation in heart following myocardial infarction via the NLRP3/IL1β pathway

Coenzyme Q10 Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials

Coenzyme Q10 Attenuates High-fat Diet-induced Non-alcoholic Fatty Liver Disease Through Activation of AMPK Pathway (P06-060-19).

Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial

The Effect of Coenzyme Q10 Supplementation on Pro-Inflammatory Factors and Adiponectin in Mildly Hypertensive Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.

Comparative Bioavailability of Different Coenzyme Q10 Formulations in Healthy Elderly Individuals

Recent Developments in the Role of Coenzyme Q10 for Coronary Heart Disease: a Systematic Review

Coenzyme Q10 attenuates platelet integrin αIIbβ3 signaling and platelet hyper-reactivity in ApoE-deficient mice.